Skip to main content
Equibles

BARCLAYS PLC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 312069 LONDON, X0
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$271,989
+$39,674 QoQ
Shares Held
18,655
+1.4% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. ENTA ranks #209 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in ENTA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $271,989 18,655
2026-03-31 $232,315 18,394
2025-12-31 $867,176 54,989
2025-09-30 $498,203 41,621
2025-06-30 $362,033 47,888
2025-03-31 $195,325 35,385
2024-12-31 $261,671 45,508
2024-09-30 $284,257 27,438
2024-06-30 $90,271 6,960
2024-03-31 $246,535 14,120
2023-12-31 $388,633 41,300
2023-09-30 $192,336 17,219
2023-06-30 $1,089,345 50,904
2023-03-31 $1,061,549 26,250
2022-12-31 $2,367,821 50,899
2022-09-30 $2,353,238 45,368
2022-06-30 $274,024 5,797
2022-03-31 $1,065,563 14,970
2021-12-31 $1,872,341 25,038
2021-09-30 $1,292,825 22,757
2021-06-30 $493,352 11,210
2021-03-31 $1,160,844 23,537
2020-12-31 $1,042,816 24,770
2020-09-30 $1,200,855 26,231
2020-06-30 $902,574 17,976
2020-03-31 $759,363 14,765